Profile
Mark Egan is Vice President of Operations for Sirna Therapeutics, Inc. He joined Sirna Therapeutics in 2001 and became Vice President of Manufacturing in December, 2003.
Dr. Egan began his career with ICI in 1990 and served as Manager of R&D Chemist and Business Project.
He received a degree in Chemistry in 1987 and a PhD in 1990 from the University of Glasgow.
Former positions of Mark Egan
| Companies | Position | End |
|---|---|---|
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Chief Operating Officer | 30/11/2006 |
ICI Group
 ICI Group Industrial SpecialtiesProcess Industries ICI Group is a British company that manufactures paints and coatings. | Corporate Officer/Principal | - |
Training of Mark Egan
| University of Glasgow | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
ICI Group
ICI Group Industrial SpecialtiesProcess Industries ICI Group is a British company that manufactures paints and coatings. | Process Industries |
- Stock Market
- Insiders
- Mark Egan
